All Stories

  1. Case Report: A Migrating Stitch in a Crohn’s Disease Patient
  2. The Use of Peppermint Oil in Gastroenterology
  3. Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care
  4. Intravenous Magnesium – Lidocaine - Ketorolac Cocktail for Postoperative Opioid Resistant Pain: A Case Series of Novel Rescue Therapy
  5. Management of Leaks Following Laparoscopic Sleeve Gastrectomy Using Specifically Designed Large Covered Metal Stents
  6. SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience
  7. Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems
  8. Metabolic Benefits of Probiotic Combination with Absorbent Smectite in type 2 Diabetes Patients a Randomised Controlled Trial
  9. Preface
  10. The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation
  11. Analysis of Nonsteroidal Anti-inflammatory Drugs by using Microfluidic Techniques: A Review
  12. Anti-Toxoplasmic Immunoglobulin G Quantitation Correlates with Immunovirological Parameters of HIV-Infected Cameroonians
  13. Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access
  14. Neonatal Hyperbilirubinemia: An Updated Appraisal of National Guidelines
  15. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives
  16. Focus on Phytochemical and Pharmacological Profile of Prunus lycioides (=Amygdalus lycioides)
  17. Indications for Non-Invasive Ventilation in Respiratory Failure
  18. Management of Gastrointestinal Bleeding in Rendu-Osler Disease
  19. Liver Cirrhosis Complications Management at the Emergency Department
  20. Disk Battery Ingestion: A Simple User-Guide
  21. Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1
  22. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding
  23. Management of Pleural Effusions in the Emergency Department
  24. Clinical Management of Infectious Diarrhea
  25. Honey Against Radiation-induced Oral Mucositis in Head and Neck Cancer Patients. An Umbrella Review of Systematic Reviews and Meta- Analyses of the Literature
  26. An Approach to Diabetic Ketoacidosis in an Emergency Setting
  27. Bedside Cardiac Pocus in Emergency Setting: A Practice Review
  28. Gut Alterations in Septic Patients: A Biochemical Literature Review
  29. New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases
  30. The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review
  31. Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?
  32. Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells
  33. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors
  34. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
  35. Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia?
  36. Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship
  37. Dealing with COVID-19: lessons learned from the Italian experience
  38. The Deadly Quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high
  39. Electrophysiological and Clinical Improvement in Non-Invasive Treatment of Carpal Tunnel Syndrome
  40. Smart Nanocarriers for Targeted Cancer Therapy
  41. Circadian rhythms of endothelial nitric oxide synthase and toll-like receptors 2 production in females with rheumatoid arthritis depending on NOS3 gene polymorphism
  42. Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey
  43. Preface
  44. A Hazelnut-Enriched Diet Modulates Oxidative Stress and Inflammation Gene Expression without Weight Gain
  45. Olive oil antioxidants and non-alcoholic fatty liver disease
  46. Effect of Chondroitin Sulfate on Blood Serum Cytokine Profile during Carrageenan-induced Edema and Monoiodoacetate-induced Osteoarthritis in Rats
  47. Preface
  48. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
  49. Rosmarinic Acid as Potential Anti-Inflammatory Agent
  50. A Systematic Review on Natural Antioxidant Properties of Resveratrol
  51. Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
  52. Basics in Endoscopic Ultrasound Part 2: EUS-guided Sampling and Therapeutic Applications
  53. Resistin levels in non-alcoholic fatty liver disease pathogenesis
  54. Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: a Case-Control Study
  55. Basics in Endoscopic Ultrasound Part 1: Diagnostic Indications and Tissue Sampling
  56. The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence
  57. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
  58. Gut microbiota changes and chronic hepatitis C virus infection
  59. Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance
  60. Polyphenols treatment in patients with nonalcoholic fatty liver disease
  61. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders
  62. Editorial (Thematic Issue: Alcoholic Liver Disease: From Bench to Bedside)
  63. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
  64. Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship
  65. Estimation of in vivo and in vitro exposure to bisphenol A as food contaminant
  66. Meet Our Editorial Board Member:
  67. Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia
  68. The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease
  69. Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
  70. Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice
  71. Non Alcoholic Fatty Liver: Epidemiology and Natural History
  72. non-alcoholic fatty liver disease
  73. Effects of Mediterranean diet supplemented with silybin–vitamin E–phospholipid complex in overweight patients with non-alcoholic fatty liver disease
  74. Non-alcoholic fatty liver disease and beneficial effects of dietary supplements
  75. Adiponectin serum level in chronic hepatitis C infection and therapeutic profile
  76. C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention
  77. Enhanced Expression of Indoleamine 2,3-Dioxygenase inHelicobacter pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production
  78. Su1939 Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production
  79. 1028 High Exposure, Spontaneous Clearance and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study
  80. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
  81. Pharmacotherapy of acute alcoholic hepatitis in clinical practice
  82. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
  83. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
  84. Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation
  85. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
  86. Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
  87. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
  88. Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center
  89. Dietary Intervention in Non-Alcoholic Fatty Liver Disease
  90. Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
  91. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study
  92. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease
  93. Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin
  94. Helicobacter species and liver disease
  95. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease
  96. Bone Mineralization in Celiac Disease
  97. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease
  98. Adiponectin levels in nonalcoholic fatty liver disease
  99. Transient Elastography for Assessment of Non-Alcoholic Fatty Liver Disease
  100. Insulin resistance increases risk of carpal tunnel syndrome: a case-control study
  101. Chronic hepatitis C infection and insulin resistance: two best friends
  102. “. . . and Suddenly a Tree!”
  103. Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease
  104. Non-alcoholic fatty liver disease and pharmacological options
  105. Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa
  106. Milk thistle in liver diseases: past, present, future
  107. Metformin: A Therapeutic Option for Treating Nonalcoholic Fatty Liver Disease
  108. Brain hypoperfusion and neurological symptoms in celiac disease
  109. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
  110. Nervous system in the gluten syndrome: A close relationship
  111. Celiac disease: from gluten to skin
  112. Behçet’s disease and celiac disease: a rare association or a possible link?
  113. Phytotherapeutic approach to alcohol dependence: New old way?
  114. Subclinical Neurological Abnormalities and Gluten-Free Diet
  115. Acute alcohol intoxication
  116. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
  117. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting
  118. Subclinical Neurological Abnormalities in Patients With Celiac Disease: Are They Associated by Brain Hypoperfusion?
  119. Complementary therapies for treating alcoholism
  120. Elastography assessment in patients with chronic HCV infection
  121. Intestinal Malabsorption and Skin Diseases
  122. Affective and Psychiatric Disorders in Celiac Disease
  123. Probiotics: Which and When?
  124. Metabolic and Nutritional Features in Adult Celiac Patients
  125. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
  126. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study
  127. Neuroendocrine and Psychological Assessment in a Guinness 10 Days Scuba Dive
  128. Analysis of the T1288R Mutation of the Wilson Disease ATP7B Gene in Four Generations of a Family: Possible Genotype-Phenotype Correlation with Hepatic Onset
  129. Celiac disease and skin: Psoriasis association
  130. Relationship Between Ghrelin Levels, Alcohol Craving, and Nutritional Status in Current Alcoholic Patients
  131. Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
  132. Complementary medicine for alcohol dependence in Italian services: A mail questionnaire
  133. Primary renal angiosarcoma: A rare malignancy. A case report and review of the literature☆
  134. Genotype–phenotype correlation of the Wilson diseaseATP7B gene
  135. Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam
  136. A New Mutation of Wilson's Disease P-Type ATPase Gene in a Patient with Cirrhosis and Coombs-Positive Hemolytic Anemia
  137. Neurobiochemical and clinical aspects of craving in alcohol addiction: A review
  138. CELIAC DISEASE AND SKIN DISORDERS
  139. Psychological Support Counseling: A New Strategy to Increase Gluten-Free Diet Compliance in Celiac Patients
  140. Association between psoriasis and coeliac disease
  141. Suppression of Craving for ??-Hydroxybutyric Acid by Naltrexone Administration
  142. Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage
  143. How Many Cravings? Pharmacological Aspects of Craving Treatment in Alcohol Addiction: A Review
  144. Neurologic Disorders in Patients With Celiac Disease: Are They Mediated by Brain Perfusion Changes?
  145. Tolerance to baclofen?s sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence
  146. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders
  147. Gluten-related cerebral hypoperfusion and neurologic disorders in coeliac patients
  148. Suppression of Alcohol Delirium Tremens by Baclofen Administration: A Case Report
  149. Rapid Regression of Psoriasis in a Coeliac Patient after Gluten-Free Diet
  150. Baclofen: clinical data